Yannick Kronimus
Boehringer Ingelheim (Germany)(DE)
Publications by Year
Research Areas
Parkinson's Disease Mechanisms and Treatments, Alzheimer's disease research and treatments, Glycosylation and Glycoproteins Research, Monoclonal and Polyclonal Antibodies Research, Neurological disorders and treatments
Most-Cited Works
- → Diacylglycerol mediates regulation of TASK potassium channels by Gq-coupled receptors(2014)89 cited
- → IgG Fc N-glycosylation: Alterations in neurologic diseases and potential therapeutic target?(2018)49 cited
- → Naturally Occurring Autoantibodies against Tau Protein Are Reduced in Parkinson's Disease Dementia(2016)25 cited
- → Serum titers of autoantibodies against α-synuclein and tau in child- and adulthood(2017)24 cited
- → Fc N‐glycosylation of autoreactive Aβ antibodies as a blood‐based biomarker for Alzheimer's disease(2023)13 cited
- → Alpha-Synuclein-Specific Naturally Occurring Antibodies Inhibit Aggregation In Vitro and In Vivo(2022)13 cited
- → Extending the functional characteristics of naturally occurring autoantibodies against β-Amyloid, Prion Protein and α-Synuclein(2018)12 cited
- → The N-terminal homology (ENTH) domain of Epsin 1 is a sensitive reporter of physiological PI(4,5)P2 dynamics(2018)9 cited
- → Effects of a Multimerized Recombinant Autoantibody Against Amyloid-β(2021)5 cited
- → Predictive stability in biopharmaceuticals and vaccines: Perspectives and recommendations towards accelerating patient access(2025)5 cited